Increased prevalence but decreased survival of nonviral hepatocellular carcinoma compared to viral hepatocellular carcinoma in recent ten years

Ting-Chun Chen,Shun-Wen Hsiao,Yang-Yuan Chen,Hsu-Heng Yen,Wei-Wen Su,Yu-Chun Hsu,Siou-Ping Huang,Pei-Yuan Su
DOI: https://doi.org/10.1038/s41598-024-59668-2
IF: 4.6
2024-04-21
Scientific Reports
Abstract:Due to the comprehensive hepatitis B virus vaccination program in Taiwan since 1986, the development of antiviral therapy for chronic hepatitis B and chronic hepatitis C infection and covered by National health insurance. Besides, the increased prevalence of nonalcoholic fatty liver disease (NAFLD) and currently, approved therapy for NAFLD remain developing. The etiology of liver-related diseases such as cirrhosis and hepatocellular carcinoma required reinterpretation. This study aimed to analyze the incidence and outcome of hepatocellular carcinoma (HCC) due to viral (hepatitis B and hepatitis C) infection compared to that of nonviral etiology. We retrospectively analyzed patients with HCC from January 2011 to December 2020 from the cancer registry at our institution. Viral-related hepatitis was defined as hepatitis B surface antigen positivity or anti-hepatitis C virus (HCV) antibody positivity. A total of 2748 patients with HCC were enrolled, of which 2188 had viral-related HCC and 560 had nonviral-related HCC. In viral HCC group, the median age at diagnosis was significantly lower (65 years versus 71 years, p < 0.001), and the prevalence of early-stage HCC, including stage 0 and stage A Barcelona Clinic Liver Cancer, was significantly higher (52.9% versus 33.6%, p < 0.001). In nonviral HCC group, alcohol use was more common (39.9% versus 30.1%, p < 0.001), the prevalence of type 2 diabetes mellitus (T2DM) was higher (54.5% versus 35.1%, p < 0.001), and obesity was common (25.0% versus 20.5%, p = 0.026). The prevalence of nonviral HCC increased significantly from 19.2 to 19.3% and 23.0% in the last 10 years ( p = 0.046). Overall survival was better in the viral HCC group (5.95 years versus 4.00 years, p < 0.001). In the early stage of HCC, overall survival was still better in the viral HCC group ( p < 0.001). The prevalence of nonviral HCC has significantly increased in the last ten years. The overall survival was significantly lower in the nonviral HCC, perhaps because the rate of early HCC detection is lower in nonviral HCC and anti-viral therapy. To detect nonviral HCC early, we should evaluate liver fibrosis in high-risk groups (including people with obesity or T2DM with NAFLD/NASH and alcoholic liver disease) and regular follow-up for those with liver fibrosis, regardless of cirrhosis.
multidisciplinary sciences
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to analyze the changes in the incidence and prognosis of viral hepatocellular carcinoma (HCC) and non - viral hepatocellular carcinoma in the past decade (from 2011 to 2020). Specifically, the study aims to: 1. **Compare the incidence of viral and non - viral HCC**: Explore whether the incidence of non - viral HCC has increased in recent years and the reasons for this increase. 2. **Evaluate the survival rate of HCC patients with different etiologies**: Analyze the overall survival rate differences between patients with viral HCC and those with non - viral HCC, and explore the factors that influence these differences. 3. **Identify high - risk groups**: Determine which factors (such as obesity, type 2 diabetes, alcohol use, etc.) are related to the occurrence and development of non - viral HCC, so as to provide a basis for early detection and prevention. By retrospectively analyzing the data of 2,748 HCC patients registered in a medical institution in Taiwan between 2011 and 2020, the research team hopes to understand these changing trends and their impact on clinical practice. The research results show that the incidence of non - viral HCC has increased significantly, but its overall survival rate is lower than that of viral HCC, which may be related to the lower early detection rate and the lack of effective antiviral treatment. Therefore, the study emphasizes the importance of regular monitoring of high - risk groups for the early detection and treatment of non - viral HCC.